Platelet activating factor receptor acts to limit colitis-induced liver inflammation

Area of Science:

• Gastroenterology
• Immunology
• Hepatology

Background:

• Liver inflammation is a common complication of inflammatory bowel disease (IBD).
• Mechanisms of gut-liver axis inflammation in IBD are not fully understood.
• IBD disrupts intestinal barrier integrity, increasing gut-derived antigens that challenge the liver.

Purpose of the Study:

• To investigate the role of platelet activating factor receptor (PAFR) in colitis-associated liver damage.
• To elucidate the mechanisms by which PAFR influences gut-liver axis inflammation.

Main Methods:

• Utilized dextran sulfate sodium (DSS) and anti-CD40-induced colitis models in mice.
• Assessed liver inflammation, PAFR protein expression, and localization.
• Investigated the inflammasome pathway (NLRP3, caspase-1, IL-1β) and Kupffer cell (KC) function.

Main Results:

• Colitis induced liver inflammation and reduced global PAFR expression, with PAFR re-localizing to the portal triad, specifically on Kupffer cells (KCs).
• PAFR expression on KCs co-localized with toll-like receptor 4.
• PAFR antagonism amplified NLRP3 inflammasome activation and IL-1β production; KC depletion exacerbated liver inflammation.

Conclusions:

• PAFR-expressing KCs exert a protective effect in colitis-associated liver injury.
• Regulation of PAFR is crucial for maintaining gut-liver axis homeostasis during IBD.